1-196943816-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005666.4(CFHR2):c.-65C>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.052 ( 49 hom., cov: 4)
Exomes 𝑓: 0.065 ( 916 hom. )
Failed GnomAD Quality Control
Consequence
CFHR2
NM_005666.4 5_prime_UTR
NM_005666.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.443
Genes affected
CFHR2 (HGNC:4890): (complement factor H related 2) This gene belongs to a family of complement factor H-related genes (CFHR), which are clustered together with complement factor H gene on chromosome 1, and are involved in regulation of complement. Mutations in CFHR genes have been associated with dense deposit disease and atypical haemolytic-uraemic syndrome. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 1-196943816-C-G is Benign according to our data. Variant chr1-196943816-C-G is described in ClinVar as [Benign]. Clinvar id is 1288324.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0878 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFHR2 | NM_005666.4 | c.-65C>G | 5_prime_UTR_variant | 1/5 | ENST00000367415.8 | NP_005657.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFHR2 | ENST00000367415 | c.-65C>G | 5_prime_UTR_variant | 1/5 | 1 | NM_005666.4 | ENSP00000356385.4 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 913AN: 17638Hom.: 49 Cov.: 4 FAILED QC
GnomAD3 genomes
AF:
AC:
913
AN:
17638
Hom.:
Cov.:
4
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0649 AC: 13112AN: 201890Hom.: 916 Cov.: 0 AF XY: 0.0658 AC XY: 7088AN XY: 107784
GnomAD4 exome
AF:
AC:
13112
AN:
201890
Hom.:
Cov.:
0
AF XY:
AC XY:
7088
AN XY:
107784
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0519 AC: 915AN: 17632Hom.: 49 Cov.: 4 AF XY: 0.0537 AC XY: 410AN XY: 7640
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
915
AN:
17632
Hom.:
Cov.:
4
AF XY:
AC XY:
410
AN XY:
7640
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 19, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at